Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Contact Lenses Pipeline Market Report Overview

A contact lens is a corrective, cosmetic, or therapeutic lens that is placed on the cornea of the eye.

The Contact Lenses pipeline market research report provides comprehensive information about the contact lens pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Soft Contact Lenses

·        Rigid Gas Permeable Contact Lenses

Key Territories ·        The US

·        Europe

·        China

·        Japan

·        South Korea

·        Singapore

·        Australia

Key Regulatory Paths ·        510(k)

·        NMPA

·        CE

·        MDITAC

·        Ninsho

·        HSA

·        ICAC

Leading Companies ·        Aeon Astron Corporation

·        Ai Kangte Medical Technology Co Ltd

·        Alcon Inc

·        Alcon Laboratories Inc

·        Apeliotus Ophthalmics (Inactive)

·        Axcelon Biopolymers Corp

·        Azalea Vision

·        Bar-Ilan University

·        Bausch & Lomb Inc

·        Bionode LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Contact Lenses Pipeline Market by Segments

The key segments in the contact lenses pipeline market are soft contact lenses and rigid gas-permeable contact lenses. As of September 2023, soft contact lenses have a higher number of pipeline products.

Contact Lenses Pipeline Market Analysis by Segments, 2023 (%)

Contact Lenses Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Contact Lenses Pipeline Market

Download A Free Report Sample

Contact Lenses Pipeline Market Segmentation by Territories

Some of the key territories in the contact lenses market are the US, Europe, China, Japan, South Korea, Singapore, and Australia. As of September 2023, the US has the highest number of pipeline products.

Contact Lenses Pipeline Market Analysis by Territories, 2023 (%)

Contact Lenses Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Contact Lenses Pipeline Market

Download A Free Report Sample

Contact Lenses Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the contact lenses pipeline market are 510(k), NMPA, CE, MDITAC, Ninsho, HSA, and ICAC. As of September 2023, 510(k) is the most followed pathway for pipeline products in the market.

Contact Lenses Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Contact Lenses Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Contact Lenses Pipeline Market

Download A Free Report Sample

Contact Lenses Pipeline Market – Competitive Landscape

Some of the key companies in the contact lenses pipeline market are Aeon Astron Corporation, Ai Kangte Medical Technology Co Ltd, Alcon Inc, Alcon Laboratories Inc, Apeliotus Ophthalmics (Inactive), Axcelon Biopolymers Corp, Azalea Vision, Bar-Ilan University, Bausch & Lomb Inc, and Bionode LLC.

Alcon Inc: It is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for the prevention and cure of blindness and different eye diseases. Alcon is headquartered in Geneva, Switzerland.

Apeliotus Ophthalmics: It is a privately held company engaged in the development of contact lens drug delivery systems. The company is engaged in manufacturing contact lenses and its products include Bandage Lens 67, Comfort Lens 67, and Contact Lens–Glaucoma 67. The company is headquartered in Atlanta, Georgia, the US.

Contact Lenses Pipeline Market Analysis by Companies, 2023

Contact Lenses Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Contact Lenses Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Contact Lenses Pipeline Market Segments Outlook

  • Soft Contact Lenses
  • Rigid Gas Permeable Contact Lenses

Contact Lenses Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • South Korea
  • Singapore
  • Australia

Contact Lenses Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE
  • MDITAC
  • Ninsho
  • HSA
  • ICAC

Scope

This report provides:

  • Extensive coverage of the contact lenses under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of contact lenses and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of contact lenses under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aeon Astron Corporation
Ai Kangte Medical Technology Co Ltd
Alcon Inc
Alcon Laboratories Inc
Apeliotus Ophthalmics (Inactive)
Axcelon Biopolymers Corp
Azalea Vision
Bar-Ilan University
Bausch & Lomb Inc
Bionode LLC
Body Organ Biomedical Corp
BVS Sight Inc
Chinese Academy of Sciences
Clerio Vision Inc
Diopter Technologies Inc (Inactive)
Euclid Systems Corp
e-Vision Medical Devices, Inc.
Eyenovations
EyeYon Medical
Fitlens Ltd
iCheck LLC
Imperial College London
Industrial Science & Technology Network Inc
Innovega Inc
Johnson & Johnson Vision Care Inc
Khalifa University
Kubota Vision Inc
Lentechs LLC
Lipocoat BV
Lynthera Corp
Massachusetts Eye and Ear Infirmary
McGowan Institute for Regenerative Medicine
Menicon Co Ltd
Mojo Vision Inc
National University of Singapore
Novartis AG
Ocular Dynamics, LLC
Ocutec Ltd
Purdue University
Queen's University
RetMap Inc
Shamir Optical Industry Ltd
Smartlens Inc
Stanford University
SynergEyes Inc
TECLens LLC
Terasaki Institute for Biomedical Innovation
The University of New South Wales press Limited
University of California
University of California San Diego
University of New Hampshire
University of Valencia
University of Washington
Verily Life Sciences
Visioneering Technologies Inc
VISTAKON Pharmaceuticals LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 13

2 Introduction 14

2.1 Contact Lenses Overview 14

3 Products under Development 15

3.1 Contact Lenses – Pipeline Products by Stage of Development 15

3.2 Contact Lenses – Pipeline Products by Segment 16

3.3 Contact Lenses – Pipeline Products by Territory 17

3.4 Contact Lenses – Pipeline Products by Regulatory Path 18

3.5 Contact Lenses – Pipeline Products by Estimated Approval Date 19

3.6 Contact Lenses – Ongoing Clinical Trials 20

4 Contact Lenses – Pipeline Products under Development by Companies 21

4.1 Contact Lenses Companies – Pipeline Products by Stage of Development 21

4.2 Contact Lenses – Pipeline Products by Stage of Development 24

5 Contact Lenses Companies and Product Overview 27

5.1 Aeon Astron Corporation Company Overview 27

5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 27

5.2 Ai Kangte Medical Technology Co Ltd Company Overview 29

5.2.1 Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.3 Alcon Inc Company Overview 32

5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 32

5.4 Alcon Laboratories Inc Company Overview 36

5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.5 Apeliotus Ophthalmics (Inactive) Company Overview 40

5.5.1 Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

5.6 Axcelon Biopolymers Corp Company Overview 42

5.6.1 Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 42

5.7 Azalea Vision Company Overview 43

5.7.1 Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview 43

5.8 Bar-Ilan University Company Overview 44

5.8.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 44

5.9 Bausch & Lomb Inc Company Overview 45

5.9.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.10 Bionode LLC Company Overview 64

5.10.1 Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.11 Body Organ Biomedical Corp Company Overview 65

5.11.1 Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 65

5.12 BVS Sight Inc Company Overview 66

5.12.1 BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.13 Chinese Academy of Sciences Company Overview 67

5.13.1 Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview 67

5.14 Clerio Vision Inc Company Overview 68

5.14.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.15 Diopter Technologies Inc (Inactive) Company Overview 69

5.15.1 Diopter Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69

5.16 Euclid Systems Corp Company Overview 70

5.16.1 Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 70

5.17 e-Vision Medical Devices, Inc. Company Overview 71

5.17.1 e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.18 Eyenovations Company Overview 72

5.18.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 72

5.19 EyeYon Medical Company Overview 73

5.19.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 Fitlens Ltd Company Overview 74

5.20.1 Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 iCheck LLC Company Overview 77

5.21.1 iCheck LLC Pipeline Products & Ongoing Clinical Trials Overview 77

5.22 Imperial College London Company Overview 78

5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 78

5.23 Industrial Science & Technology Network Inc Company Overview 79

5.23.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.24 Innovega Inc Company Overview 80

5.24.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.25 Johnson & Johnson Vision Care Inc Company Overview 82

5.25.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.26 Khalifa University Company Overview 84

5.26.1 Khalifa University Pipeline Products & Ongoing Clinical Trials Overview 84

5.27 Kubota Vision Inc Company Overview 85

5.27.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.28 Lentechs LLC Company Overview 86

5.28.1 Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview 86

5.29 Lipocoat BV Company Overview 89

5.29.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 89

5.30 Lynthera Corp Company Overview 90

5.30.1 Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview 90

5.31 Massachusetts Eye and Ear Infirmary Company Overview 93

5.31.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 93

5.32 McGowan Institute for Regenerative Medicine Company Overview 94

5.32.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 94

5.33 Menicon Co Ltd Company Overview 95

5.33.1 Menicon Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

5.34 Mojo Vision Inc Company Overview 97

5.34.1 Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 97

5.35 National University of Singapore Company Overview 98

5.35.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 98

5.36 Novartis AG Company Overview 99

5.36.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 99

5.37 Ocular Dynamics, LLC Company Overview 100

5.37.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 100

5.38 Ocutec Ltd Company Overview 101

5.38.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.39 Purdue University Company Overview 102

5.39.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 102

5.40 Queen’s University Company Overview 104

5.40.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 104

5.41 RetMap Inc Company Overview 105

5.41.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.42 Shamir Optical Industry Ltd Company Overview 106

5.42.1 Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

5.43 Smartlens Inc Company Overview 107

5.43.1 Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.44 Stanford University Company Overview 108

5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

5.45 SynergEyes Inc Company Overview 109

5.45.1 SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.46 TECLens LLC Company Overview 110

5.46.1 TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview 110

5.47 Terasaki Institute for Biomedical Innovation Company Overview 113

5.47.1 Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview 113

5.48 The University of New South Wales press Limited Company Overview 114

5.48.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview 114

5.49 University of California Company Overview 115

5.49.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 115

5.50 University of California San Diego Company Overview 116

5.50.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 116

5.51 University of New Hampshire Company Overview 117

5.51.1 University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview 117

5.52 University of Valencia Company Overview 118

5.52.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 118

5.53 University of Washington Company Overview 120

5.53.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 120

5.54 Verily Life Sciences Company Overview 122

5.54.1 Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 122

5.55 Visioneering Technologies Inc Company Overview 123

5.55.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 123

5.56 VISTAKON Pharmaceuticals LLC Company Overview 131

5.56.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 131

6 Contact Lenses- Recent Developments 132

6.1 Sep 08, 2023: Ocean Insight Names Richard Curran as President 132

6.2 Aug 30, 2023: CooperCompanies Announces Third Quarter 2023 Results 132

6.3 Aug 28, 2023: Novartis to Let Go 100 Employees in Latest Round of Layoffs 134

6.4 Aug 15, 2023: Alcon Reports Second Quarter 2023 Results 134

6.5 Jul 13, 2023: Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3 140

6.6 May 15, 2023: Menicon Co. Notice of Agenda Items for the 66th Annual General Meeting of Shareholders 140

6.7 May 08, 2023: Hoya announces consolidated financial results for the fiscal year ended March 31, 2023 140

6.8 Apr 27, 2023: CooperCompanies announces release date for second quarter 2023 140

6.9 Apr 20, 2023: EssilorLuxottica reports Q1 2023 revenue 140

6.10 Feb 27, 2023: Menicon Notice Regarding Change in Representative Executive Officers and Personnel Changes in Executive Officers 141

6.11 Feb 23, 2023: Fielmann Announces Preliminary Figures for FY2022/Dividend 141

6.12 Feb 23, 2023: EssilorLuxotticaFY 2022 Results Year of records in sales, operating and net profit 143

6.13 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23 144

6.14 Feb 02, 2023: Cooper Companies Announces Release Date for First Quarter 2023 145

6.15 Feb 01, 2023: Novartis Announces Annual Report 2022 145

6.16 Feb 01, 2023: Newly launched multifocal colored contact lens 2WEEK Menicon Rei multifocal realizes natural vision from near to distance 147

6.17 Jan 31, 2023: Hoya Announces Fourth semi-annual financial statements 148

6.18 Jan 30, 2023: Yael Kusch Appointed Global Public Relations Manager Of Essilorluxottica 149

6.19 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22 149

6.20 Dec 19, 2022: CooperCompanies Sets Annual Meeting and Stockholder Record Dates 150

6.21 Nov 30, 2022: Elegance Optical International Holdings announces Interim Results for the Six Months Ended 30 September 2022 150

6.22 Nov 15, 2022: Bausch + Lomb reports more than 58 million units of contact lens, lens care and eye care materials collected through ONE By ONE and Biotrue eye care recycling programs 152

6.23 Nov 02, 2022: Fielmann AG: ad hoc announcement for the third quarter 152

6.24 Oct 13, 2022: Novartis to lay off 400 at Dublin campus amid global restructuring 154

6.25 Oct 13, 2022: Novartis to cut its Irish workforce by up to 25% 154

6.26 Oct 11, 2022: Elegance Optical International Announces Resignation of Executive Directors, Chairman of the Board and Authorised Representative 154

6.27 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2 155

6.28 Sep 29, 2022: 1-800 Contacts Appoints Angie Balfour as Chief People Officer 155

6.29 Sep 29, 2022: QITIAN Technology Group Announces on the Appointment of Senior Management Personnel 156

6.30 Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations 156

6.31 Sep 28, 2022: Shanghai Conant Optical Co Ltd announced interim report for 2022 157

6.32 Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting 157

7 Appendix 159

7.1 Methodology 159

7.2 About GlobalData 162

7.3 Contact Us 162

7.4 Disclaimer 162

Table

Contact Lenses – Pipeline Products by Stage of Development 15

Contact Lenses – Pipeline Products by Segment 16

Contact Lenses – Pipeline Products by Territory 17

Contact Lenses – Pipeline Products by Regulatory Path 18

Contact Lenses – Pipeline Products by Estimated Approval Date 19

Contact Lenses – Ongoing Clinical Trials 20

Contact Lenses Companies – Pipeline Products by Stage of Development 21

Contact Lenses – Pipeline Products by Stage of Development 24

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 27

Biolens – Product Status 27

Biolens – Product Description 27

Contact Lens – Product Status 28

Contact Lens – Product Description 28

Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Multifocal Contact Lens (Muti-Focal RGP) – Myopia – Product Status 29

Multifocal Contact Lens (Muti-Focal RGP) – Myopia – Product Description 29

Multifocal Contact Lens (Muti-Focal RGP) – Ocular Surface Disease – Product Status 30

Multifocal Contact Lens (Muti-Focal RGP) – Ocular Surface Disease – Product Description 30

Multifocal Contact Lens (Muti-Focal RGP) – Vision Correction – Product Status 30

Multifocal Contact Lens (Muti-Focal RGP) – Vision Correction – Product Description 30

Orthokeratology Lens – Myopia – Product Status 31

Orthokeratology Lens – Myopia – Product Description 31

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Status 32

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Description 33

Dailies Total 1 Colors SiHy Lens – Product Status 33

Dailies Total 1 Colors SiHy Lens – Product Description 33

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Status 34

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Description 34

Weekly WG SiHy Lens – Product Status 34

Weekly WG SiHy Lens – Product Description 35

Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Total30 Asphere – Product Status 36

Total30 Asphere – Product Description 36

Total30 For Astigmatism – Product Status 37

Total30 For Astigmatism – Product Description 37

Total30 Multifocal – Product Status 37

Total30 Multifocal – Product Description 38

Total30 Multifocal Toric – Product Status 38

Total30 Multifocal Toric – Product Description 38

TOTAL30 Soft Contact Lenses – Product Status 39

TOTAL30 Soft Contact Lenses – Product Description 39

Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

Comfort Lens – Product Status 40

Comfort Lens – Product Description 40

Contact Lens – Glaucoma – Product Status 41

Contact Lens – Glaucoma – Product Description 41

Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 42

PolyHEMA-BNC Based Contact Lens – Product Status 42

PolyHEMA-BNC Based Contact Lens – Product Description 42

Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview 43

Smart Contact Lens – Product Status 43

Smart Contact Lens – Product Description 43

Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 44

Bionic Contact Lens – Product Status 44

Bionic Contact Lens – Product Description 44

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Aqualox SiHy Daily Lens – Product Status 46

Aqualox SiHy Daily Lens – Product Description 46

Bausch + Lomb Infuse Multifocal Contact Lenses – Product Status 46

Bausch + Lomb Infuse Multifocal Contact Lenses – Product Description 47

BLC – 001: SVS – Product Status 47

BLC – 001: SVS – Product Description 47

BLC – 002: SVS – Product Status 48

BLC – 002: SVS – Product Description 48

BLC – 003: SVS/MF/fA – Product Status 48

BLC – 003: SVS/MF/fA – Product Description 49

BLC – 004: Toric – Product Status 49

BLC – 004: Toric – Product Description 49

BLC – 005: SVS/MF – Product Status 50

BLC – 005: SVS/MF – Product Description 50

BLC – 006: SVS – Product Status 50

BLC – 006: SVS – Product Description 51

BLC – 007: MF – Product Status 51

BLC – 007: MF – Product Description 51

BLC – 008: Astigmatism – Product Status 52

BLC – 008: Astigmatism – Product Description 52

BLC – 009: Astigmatism – Product Status 52

BLC – 009: Astigmatism – Product Description 52

Contact Lens – Myopia – Product Status 53

Contact Lens – Myopia – Product Description 53

Custom Soft Contact Lens – Product Status 53

Custom Soft Contact Lens – Product Description 54

Forge Orthokeratology Lenses – Product Status 54

Forge Orthokeratology Lenses – Product Description 54

Myopia Control Contact Lens – Product Status 55

Myopia Control Contact Lens – Product Description 55

SiHy Daily Multi-Focal Lens – Product Status 55

SiHy Daily Multi-Focal Lens – Product Description 56

SiHy Daily Toric Lens – Product Status 56

SiHy Daily Toric Lens – Product Description 56

Ultra Plus Powers Lens – Product Status 56

Ultra Plus Powers Lens – Product Description 57

XUV – 003: Aphakia – Product Status 57

XUV – 003: Aphakia – Product Description 57

XUV – 004: SVS – Product Status 58

XUV – 004: SVS – Product Description 58

XUV – 007: MF – Product Status 58

XUV – 007: MF – Product Description 59

XUV – 009: SVS – Product Status 59

XUV – 009: SVS – Product Description 59

XUV – 010: Astigmatism – Product Status 60

XUV – 010: Astigmatism – Product Description 60

XUV – 011: MF – Product Status 60

XUV – 011: MF – Product Description 61

XUV – 012: SVS – Product Status 61

XUV – 012: SVS – Product Description 61

XUV – 013: Astigmatism – Product Status 62

XUV – 013: Astigmatism – Product Description 62

XUV – 014: Presbyopia – Product Status 62

XUV – 014: Presbyopia – Product Description 63

XUV – 015: MF – Product Status 63

XUV – 015: MF – Product Description 63

Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview 64

Bionode IOP Lowering System – Product Status 64

Bionode IOP Lowering System – Product Description 64

Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 65

Collagen Lens – Product Status 65

Collagen Lens – Product Description 65

BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Smart Contact Lens – Product Status 66

Smart Contact Lens – Product Description 66

Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview 67

Smart Contact Lens – Eye Health Monitoring – Product Status 67

Smart Contact Lens – Eye Health Monitoring – Product Description 67

Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Bifocal Contact Lens – Product Status 68

Bifocal Contact Lens – Product Description 68

Diopter Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 69

Drug Eluting Contact Lens – Product Status 69

Drug Eluting Contact Lens – Product Description 69

Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 70

Drug-Eluting Contact Lenses – Product Status 70

Drug-Eluting Contact Lenses – Product Description 70

e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

Electronic Contact Lens – Product Status 71

Electronic Contact Lens – Product Description 71

Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 72

Drug Dispensing Contact Lens – Product Status 72

Drug Dispensing Contact Lens – Product Description 72

EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 73

Hyper-CL – Drug Delivery – Product Status 73

Hyper-CL – Drug Delivery – Product Description 73

Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

Myolens – Product Status 74

Myolens – Product Description 74

Fitlens Ltd – Ongoing Clinical Trials Overview 75

Myolens – An Open Label, 3 Arms, Multicenter, Randomized. To Evaluate the Effectiveness Fitlens Soft Central Near and Central Far Contact Lens, Compared With MiSight for the Control of Progressive Juvenile Onset Myopia in Children Ages 8-12 76

iCheck LLC Pipeline Products & Ongoing Clinical Trials Overview 77

iCheck Active Contact Lens – Product Status 77

iCheck Active Contact Lens – Product Description 77

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 78

Contact Lens – Product Status 78

Contact Lens – Product Description 78

Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Silicone Hydrogel Contact Lens – Product Status 79

Silicone Hydrogel Contact Lens – Product Description 79

Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview 80

eMacula VR Contact Lenses – Product Status 80

eMacula VR Contact Lenses – Product Description 80

iOptik Contact Lens – Product Status 81

iOptik Contact Lens – Product Description 81

Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview 82

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Status 82

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Description 82

Xlens – Product Status 83

Xlens – Product Description 83

Khalifa University Pipeline Products & Ongoing Clinical Trials Overview 84

Gold Nanocomposite Contact Lens – Product Status 84

Gold Nanocomposite Contact Lens – Product Description 84

Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 85

Smart Contact Lens – Myopia – Product Status 85

Smart Contact Lens – Myopia – Product Description 85

Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview 86

Apioc – Astigmatism – Product Status 86

Apioc – Astigmatism – Product Description 86

Apioc – Presbyopia – Product Status 87

Apioc – Presbyopia – Product Description 87

Apioc – Presbyopia With Astigmatism – Product Status 87

Apioc – Presbyopia With Astigmatism – Product Description 88

Apioc Sphere – Astigmatism – Product Status 88

Apioc Sphere – Astigmatism – Product Description 88

Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview 89

Lipocoat-Enabled Contact Lens – Product Status 89

Lipocoat-Enabled Contact Lens – Product Description 89

Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview 90

Contact Lens Device – Dry Eye Disease – Product Status 90

Contact Lens Device – Dry Eye Disease – Product Description 90

Drug-Delivering Contact Lens (DDCL) – Product Status 91

Drug-Delivering Contact Lens (DDCL) – Product Description 91

Ketotifen Drug Delivery Contact Lens – Product Status 91

Ketotifen Drug Delivery Contact Lens – Product Description 92

Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 93

Therapeutic Contact Lens – Product Status 93

Therapeutic Contact Lens – Product Description 93

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 94

Drug-Eluting Contact Lens – Product Status 94

Drug-Eluting Contact Lens – Product Description 94

Menicon Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

Menicon Z Night – Product Status 95

Menicon Z Night – Product Description 96

Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 97

Mojo Lens – Product Status 97

Mojo Lens – Product Description 97

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 98

Multi – Focal Contact Lens – Product Status 98

Multi – Focal Contact Lens – Product Description 98

Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 99

CLM041 – Product Status 99

CLM041 – Product Description 99

Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 100

Bio-inspired Contact Lens – Dry Eye Disease – Product Status 100

Bio-inspired Contact Lens – Dry Eye Disease – Product Description 100

Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

Third PEG Hydrogel Contact Lens – Product Status 101

Third PEG Hydrogel Contact Lens – Product Description 101

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 102

Soft Contact Lens – Product Status 102

Soft Contact Lens – Product Description 102

Soft Contact Lens – Ocular Disease Monitoring – Product Status 103

Soft Contact Lens – Ocular Disease Monitoring – Product Description 103

Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 104

Non-Invasive IOP Monitoring Soft Contact Lens – Product Status 104

Non-Invasive IOP Monitoring Soft Contact Lens – Product Description 104

RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview 105

CLEAr Lens – Product Status 105

CLEAr Lens – Product Description 105

Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

MyLens – Product Status 106

MyLens – Product Description 106

Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview 107

miLens – Product Status 107

miLens – Product Description 107

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 108

Polymer Network Hydrogel Contact Lens – Product Status 108

Polymer Network Hydrogel Contact Lens – Product Description 108

SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview 109

ScanFitPRO – Product Status 109

ScanFitPRO – Product Description 109

TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview 110

CXLens Device – Product Status 110

CXLens Device – Product Description 110

TECLens LLC – Ongoing Clinical Trials Overview 111

CXLens Device – A Pilot Clinical Study for the Treatment of Keratoconus using the TECLens CXLens on-eye Cross-linking System for Corneal Remodeling 112

Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview 113

Hydrogel Contact Lens – Biomarker Sensing – Product Status 113

Hydrogel Contact Lens – Biomarker Sensing – Product Description 113

The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview 114

Stem Cell Contact Lens – Product Status 114

Stem Cell Contact Lens – Product Description 114

University of California Pipeline Products & Ongoing Clinical Trials Overview 115

Bandage Contact Lens – Product Status 115

Bandage Contact Lens – Product Description 115

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 116

Telescopic Contact Lens – Product Status 116

Telescopic Contact Lens – Product Description 116

University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview 117

Hydrogel Contact Lens – Product Status 117

Hydrogel Contact Lens – Product Description 117

University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 118

Multifocal Contact Lens – Myopia – Product Status 118

Multifocal Contact Lens – Myopia – Product Description 118

Multifocal Contact Lens – Presbyopia – Product Status 119

Multifocal Contact Lens – Presbyopia – Product Description 119

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 120

Bionic Contact Lens – Product Status 120

Bionic Contact Lens – Product Description 120

Solar Powered Augmented Lenses – Product Status 121

Solar Powered Augmented Lenses – Product Description 121

Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 122

Smart Contact Lens – Diabetes – Product Status 122

Smart Contact Lens – Diabetes – Product Description 122

Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 123

Bespoke Corneal GP Lenses – Product Status 123

Bespoke Corneal GP Lenses – Product Description 124

Contact Lens – Product Status 124

Contact Lens – Product Description 124

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Product Status 125

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Product Description 125

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Status 125

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Description 126

NaturalVue Toric 1 Day Contact Lenses – Product Status 126

NaturalVue Toric 1 Day Contact Lenses – Product Description 126

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Status 127

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Description 127

Next Gen NaturalVue MF Contact Lens – Product Status 127

Next Gen NaturalVue MF Contact Lens – Product Description 128

VTI MPC Lens – Product Status 128

VTI MPC Lens – Product Description 128

Visioneering Technologies Inc – Ongoing Clinical Trials Overview 129

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Myopia Control in the Pediatric Population: A Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05% 130

NaturalVue (etafilcon A) Multifocal 1 Day Contact Lens – Myopia Progression in Children and Adolescents Before and after Use of a Novel Extended Depth of Focus Daily Disposable Soft Contact Lens 130

VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 131

K-Lens – Product Status 131

K-Lens – Product Description 131

Glossary 161

Figures

Contact Lenses – Pipeline Products by Stage of Development 15

Contact Lenses – Pipeline Products by Segment 16

Contact Lenses – Pipeline Products by Territory 17

Contact Lenses – Pipeline Products by Regulatory Path 18

Contact Lenses – Pipeline Products by Estimated Approval Date 19

Contact Lenses – Ongoing Clinical Trials 20

Frequently asked questions

Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Contact Lenses Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.